It is best to avoid alcohol, during treatment and for two months after treatment when Novatretin is completed.
It is best to avoid alcohol, during treatment and for two months after treatment when Novatretin is completed.
For the treatment of severe psoriasis. It is important to read and understand this information.

WARNING: CAUSES BIRTH DEFECTS. DO NOT USE IF PREGNANT. Do not become pregnant during use or within 3 years of stopping treatment.
ATTENTION: Adhere strictly to precautions.
TAPS MR12507

Take extra care to avoid sunburn by wearing covering clothing and using sunscreens.
While you are taking Novatretin you will have to take a little extra care of your skin.
Zito PM, Patel P, Mazzoni T. Acitretin. StatPearls. Treasure Island (FL)2025.
Damiani G, Bragazzi NL, Karimkhani Aksut C, Wu D, Alicandro G, McGonagle D, et al. The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study. Front Med (Lausanne). 2021;8:743180.
Armstrong AW. Psoriasis. JAMA Dermatol. 2017;153(9):956.
Zhou X, Chen Y, Cui L, Shi Y, Guo C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 2022;13(1):81.
Ogawa K, Okada Y. The current landscape of psoriasis genetics in 2020. J Dermatol Sci. 2020;99(1):2-8.
Hao Y, Zhu YJ, Zou S, Zhou P, Hu YW, Zhao QX, et al. Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions. Front Immunol. 2021;12:711060.
Schmieder SJ, Sathe NC, Rosario-Collazo JA. Darier Disease. StatPearls. Treasure Island (FL)2025.
Ettinger M, Kimeswenger S, Deli I, Traxler J, Altrichter S, Noack P, et al. Darier disease: Current insights and challenges in pathogenesis and management. J Eur Acad Dermatol Venereol. 2025;39(5):942-51.
Majmundar VD, Baxi K. Hereditary and Acquired Ichthyosis Vulgaris. StatPearls. Treasure Island (FL)2025.
Miceli A, Schmieder GJ. Palmoplantar Psoriasis. StatPearls. Treasure Island (FL)2025.
Chan JJ. Psoriasis: an update on topical and systemic therapies. Aust Prescr. 2025;48(3):87-92.
Thomas BR, O’Toole EA. Diagnosis and Management of Inherited Palmoplantar Keratodermas. Acta Derm Venereol. 2020;100(7):adv00094.
NOVATRETIN (Acitretin 10 mg and 25 mg capsules) is a prescription medicine for the treatment of severe Psoriasis and other severe skin disorders.
Dosage and administration: Your doctor will determine exactly how many NOVATRETIN capsules to take each day.
The starting dose is usually either 25 mg ( 1 x 25 mg capsule) or 30 mg ( 3 x 10 mg capsules) per day for 2 to 4 weeks.
Contraindications: This medicine can cause birth defects.
This means you must use strict birth control for at least 1 month before you start NOVATRETIN, the whole time you are taking NOVATRETIN and for at least 3 years after you finish.
Precautions: Inform your doctor if you take vitamin supplements that contain greater the 2500 IU of Vitamin A. Consumption of alcohol should be avoided during treatment and 2 months after finishing treatment with NOVATRETIN.
Paediatric Use: NOVATRETIN capsules should only be taken by children where alternative therapy cannot be used.
Pregnancy: NOVATRETIN ® should not be used during pregnancy or for 3 years after you stop taking the treatment.
Adverse effects: Common side effects can include: dryness of the lips, mouth, nose, eyes and skin, thirst, flushing, difficulty producing tears, intolerance of contact lenses, itchiness, redness or rashes, thinning or peeling of the skin, nail fragility, eye infections, abnormal liver tests, increase in blood cholesterol, muscle, joint and bone pain.
Reporting of suspected adverse reactions: drugsafety@douglas.co.nz
Storage: Keep your capsules in a cool dry place where the temperature stays at or below 25 degrees Celcius.
Ask your doctor if NOVATRETIN is right for you. Use strictly as directed. If symptoms continue or you have side effects, see your doctor, pharmacist or healthcare professional.
NOVATRETIN HAS RISKS AND BENEFITS
NOVATRETIN is listed on the Pharmaceutical Schedule and normal doctor/prescription charges apply.
Additional product information and Consumer Medicine
Information can be found at www.medsafe.govt.nz/Consumers/cmi/n/Novatretin.pdf or free phone Douglas 0800 368 452
Distributed by Douglas Pharmaceuticals Ltd, Auckland 0610. New Zealand. www.douglas.co.nz.
TAPS MR12507